In vitro effects of MYCN sense and antisense expression in MYCN-amplified human neuroblastoma cells

被引：0

作者：

Kavallaris, M ^{[1
]}

Gardaneh, M ^{[1
]}

Cheung, B ^{[1
]}

Camacho, ML ^{[1
]}

Hocker, JE ^{[1
]}

Norris, MD ^{[1
]}

Haber, M ^{[1
]}

Marshall, GM ^{[1
]}

机构：

[1] Sydney Childrens Hosp, Childrens Canc Res Inst, Randwick, NSW 2031, Australia

来源：

ANTICANCER RESEARCH | 1998年 / 18卷 / 3A期

关键词：

MYCN; neuroblastoma; antisense RNA;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Amplification of the MYCN oncogene is a strong predictor of treatment failure and chemo-resistance in childhood neuroblastoma. Stable expression of two partial MYCN gene fragments in antisense orientation reduced Mycn protein expression in an MYCN-amplified neuroblastoma tumor cell line, however; antisense cells did not exhibit an increased in vitro sensitivity to cytotoxic ol differentiating agents. In contrast, partial MYCN sense transfectants exhibited increased resistance to cytotoxic drugs. These data suggest that the chemo-resistance of MYCN-amplified neuroblastoma cells is complex, and may be due to factors additional to Mycn protein expression.

引用

页码：1793 / 1797

页数：5

共 50 条

[21] A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma
Zhang, Hai-Feng
Delaidelli, Alberto
Javed, Sumreen
Turgu, Busra
Hughes, Christopher S.
Yang, Xiaqiu
Lizardo, Michael
Martinez, Daniel
Maris, John M.
Bosse, Kristopher R.
Williams, Karla C.
Sorensen, Poul H.
CANCER RESEARCH, 2023, 83 (07)
[22] Assessing the role of bivalency in MYCN-amplified neuroblastoma.
Chennakesavalu, Mohansrinivas
Chaves, Gepoliano
Moore, Kelley
Wu, Tong
Lyu, Ruitu
TerHaar, Rachel
Chlenski, Alexandre
He, Chuan
Cohn, Susan
Piunti, Andrea
Applebaum, Mark
CANCER RESEARCH, 2022, 82 (23)
[23] A MYCN-INDEPENDENT MECHANISM MEDIATING SECRETOME REPROGRAMMING AND METASTASIS IN MYCN-AMPLIFIED NEUROBLASTOMA
Zhang, Hai-Feng
Delaidelli, Alberto
Javed, Sumreen
Turgu, Busra
Yang, Xiaqiu
Lizardo, Michael
Martinez, Daniel
Maris, John
Bosse, Kristopher
Williams, Karla
Sorensen, Poul
PEDIATRIC BLOOD & CANCER, 2023, 70 : S67 - S68
[24] Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma
Henriksen, Jorn R.
Haug, Bjorn Helge
Buechner, Jochen
Tomte, Ellen
Lokke, Cecilie
Flaegstad, Trond
Einvik, Christer
BMC DEVELOPMENTAL BIOLOGY, 2011, 11
[25] Microarray expression analysis of MYCN-amplified neuroblastoma cells after inhibition of CDK2
Song, H.
Wu, F.
Li, S.
Wang, Z.
Liu, X.
Cui, Y.
Lin, C.
NEOPLASMA, 2017, 64 (03) : 351 - 357
[26] Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
Hald, Oyvind H.
Olsen, Lotte
Gallo-Oller, Gabriel
Elfman, Lotta Helena Maria
Lokke, Cecilie
Kogner, Per
Sveinbjornsson, Baldur
Flaegstad, Trond
Johnsen, John Inge
Einvik, Christer
ONCOGENE, 2019, 38 (15) : 2800 - 2813
[27] The development of a new murine MYCN-amplified neuroblastoma cell line
Stermann, A.
Huebener, N.
Fest, S.
Woehler, A.
Baykan, B.
Gaedicke, G.
Lode, H. N.
KLINISCHE PADIATRIE, 2008, 220 (03): : 208 - 209
[28] Ablation of oncogenic MYCN expression by hTERT-driven oncolytic adenovirus induces cell death in MYCN-amplified neuroblastoma
Tanimoto, Terutaka
Tazawa, Hiroshi
Noso, Hiroshi
Oyama, Takanori
Urata, Yasuo
Kagawa, Shunsuke
Noda, Takuo
Fujiwara, Toshiyoshi
CANCER RESEARCH, 2017, 77
[29] TFAP4 inhibits differentiation of MYCN-amplified neuroblastoma
Zhang, Shuobo
Lopez, Gonzalo
Yu, Jiyang
Silva, Jose
Kadenhe-Chiweshe, Angela
Califano, Andrea
Yamashiro, Darrell
CANCER RESEARCH, 2015, 75
[30] The mechanisms underlying the sensitivity to thymidylate synthase inhibitors in MYCN-amplified neuroblastoma cells
Kiyonari, Shinichi
Sakai, Ryuichi
Kadomatsu, Kenji
CANCER SCIENCE, 2022, 113 : 1771 - 1771

← 1 2 3 4 5 →